Literature DB >> 18799119

A roadmap for understanding and preventing necrotizing enterocolitis.

Josef Neu1, Maka Mshvildadze, Volker Mai.   

Abstract

Necrotizing enterocolitis (NEC) is the most common severe gastrointestinal emergency that affects newborns. Its etiology is still undetermined. Most of our knowledge of this disease stems from epidemiologic studies, clinical experience, and studies using animal models that do not directly represent the disease in premature infants. An immature intestine that is colonized by bacteria is a prerequisite for the pathogenesis of NEC. Although causative microbes have not been found, newly developed analytic techniques now allow the detection of noncultivatable microbes and the determination of their overall diversity and metabolic capabilities. The National Institutes of Health Human Microbiome Roadmap Project is likely to generate new information highly germane to understanding NEC. Newly developed proteomic and metabolomic approaches also offer exciting new potential for early diagnosis and prevention of this disease in infants at highest risk.

Entities:  

Mesh:

Year:  2008        PMID: 18799119     DOI: 10.1007/s11894-008-0084-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  63 in total

1.  Feeding intolerance in very-low-birthweight infants: what is it and what can we do about it?

Authors:  Josef Neu; Liyan Zhang
Journal:  Acta Paediatr Suppl       Date:  2005-10

Review 2.  Donor milk: what's in it and what's not.

Authors:  D B Tully; F Jones; M R Tully
Journal:  J Hum Lact       Date:  2001-05       Impact factor: 2.219

3.  Probiotic potential of 3 Lactobacilli strains isolated from breast milk.

Authors:  Rocío Martín; Mónica Olivares; María L Marín; Leonides Fernández; Jordi Xaus; Juan M Rodríguez
Journal:  J Hum Lact       Date:  2005-02       Impact factor: 2.219

4.  Bacterial imprinting of the neonatal immune system: lessons from maternal cells?

Authors:  Pablo F Perez; Joël Doré; Marion Leclerc; Florence Levenez; Jalil Benyacoub; Patrick Serrant; Iris Segura-Roggero; Eduardo J Schiffrin; Anne Donnet-Hughes
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

5.  The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away.

Authors:  John C Alverdy; Eugene B Chang
Journal:  J Leukoc Biol       Date:  2007-12-26       Impact factor: 4.962

Review 6.  Neonatal necrotizing enterocolitis, a disease of the immature intestinal mucosal barrier.

Authors:  E J Israel
Journal:  Acta Paediatr Suppl       Date:  1994

7.  Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium.

Authors:  Marie-France de la Cochetiere; Hugues Piloquet; Clotilde des Robert; Dominique Darmaun; Jean-Paul Galmiche; Jean-Christophe Roze
Journal:  Pediatr Res       Date:  2004-06-16       Impact factor: 3.756

Review 8.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

9.  Angiogenins: a new class of microbicidal proteins involved in innate immunity.

Authors:  Lora V Hooper; Thaddeus S Stappenbeck; Chieu V Hong; Jeffrey I Gordon
Journal:  Nat Immunol       Date:  2003-01-27       Impact factor: 25.606

10.  The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis.

Authors:  D M Anderson; R M Kliegman
Journal:  Am J Perinatol       Date:  1991-01       Impact factor: 1.862

View more
  20 in total

1.  Risk factors and outcome in neonatal necrotising enterocolitis.

Authors:  Bahubali Gane; B Vishnu Bhat; B Adhisivam; Rojo Joy; P Prasadkumar; P Femitha; B Shruti
Journal:  Indian J Pediatr       Date:  2014-01-04       Impact factor: 1.967

Review 2.  Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease.

Authors:  Collin L Ellis; John C Rutledge; Mark A Underwood
Journal:  Gut Microbes       Date:  2010 Nov-Dec

Review 3.  New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention.

Authors:  Michael P Sherman
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

Review 4.  Necrotizing enterocolitis: It's not all in the gut.

Authors:  Alissa L Meister; Kim K Doheny; R Alberto Travagli
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

5.  S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.

Authors:  Taiming Liu; Hobe J Schroeder; Meijuan Zhang; Sean M Wilson; Michael H Terry; Lawrence D Longo; Gordon G Power; Arlin B Blood
Journal:  Nitric Oxide       Date:  2016-05-25       Impact factor: 4.427

Review 6.  Necrotizing enterocolitis risk: state of the science.

Authors:  Sheila M Gephart; Jacqueline M McGrath; Judith A Effken; Melissa D Halpern
Journal:  Adv Neonatal Care       Date:  2012-04       Impact factor: 1.968

Review 7.  Microecology, intestinal epithelial barrier and necrotizing enterocolitis.

Authors:  Renu Sharma; Joseph J Tepas
Journal:  Pediatr Surg Int       Date:  2009-12-05       Impact factor: 1.827

8.  Investigators' perspectives on translating human microbiome research into clinical practice.

Authors:  M J Slashinski; S N Whitney; L S Achenbaum; W A Keitel; S A McCurdy; A L McGuire
Journal:  Public Health Genomics       Date:  2013-04-24       Impact factor: 2.000

9.  Expert consensus building using e-Delphi for necrotizing enterocolitis risk assessment.

Authors:  Sheila M Gephart; Judith A Effken; Jacqueline M McGrath; Pamela G Reed
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2013-04-18

10.  Ghrelin ameliorates the phenotype of newborn rats induced with mild necrotizing enterocolitis.

Authors:  Alissa L Meister; Cameron R Burkholder; Kim K Doheny; R Alberto Travagli
Journal:  Neurogastroenterol Motil       Date:  2019-08-06       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.